Literature DB >> 6974167

The semi-synthetic thienamycin derivative MK0787 and its properties with respect to a range of beta-lactamases from clinically relevant bacterial species.

M H RIchmond.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6974167     DOI: 10.1093/jac/7.3.279

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  23 in total

1.  Bile levels of imipenem in patients with T-drain following the administration of imipenem/cilastatin.

Authors:  M Mayer; C Tophof; W Opferkuch
Journal:  Infection       Date:  1988 Jul-Aug       Impact factor: 3.553

2.  Comparative in vitro activity of imipenem against Haemophilus influenzae and Haemophilus parainfluenzae.

Authors:  A T Cerami; D L Shungu
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

3.  [Clinical significance of beta-lactamase inhibitors].

Authors:  D Adam
Journal:  Klin Wochenschr       Date:  1988-01-15

4.  In vitro activity against aerobic and anaerobic gram-positive and gram-negative bacteria and beta-lactamase stability of RS-533, a novel carbapenem.

Authors:  H C Neu; N X Chin; G Saha; P Labthavikul
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

Review 5.  In vitro activity of imipenem--a review.

Authors:  I Braveny
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

6.  Novel carbapenem derivative SF2103A: studies on the mode of beta-lactamase inactivation.

Authors:  A Yamaguchi; T Hirata; T Sawai
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

7.  Pharmacokinetics and tolerance of N-formimidoyl thienamycin (MK0787) in humans.

Authors:  S R Norrby; K Alestig; F Ferber; J L Huber; K H Jones; F M Kahan; M A Meisinger; J D Rogers
Journal:  Antimicrob Agents Chemother       Date:  1983-02       Impact factor: 5.191

Review 8.  Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  S P Clissold; P A Todd; D M Campoli-Richards
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

9.  A comparison of the antibacterial activities of N-formimidoyl thienamycin (MK0787) with those of other recently developed beta-lactam derivatives.

Authors:  W Cullmann; W Opferkuch; M Stieglitz; U Werkmeister
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

10.  Pharmacokinetics of imipenem and cilastatin after their simultaneous administration to the elderly.

Authors:  S Toon; K J Hopkins; F M Garstang; L Aarons; M Rowland
Journal:  Br J Clin Pharmacol       Date:  1987-02       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.